News & Updates

Sunshine vitamin, calcium may help avert bone loss associated with AIs

18 Jan 2022 by

Supplementation with vitamin D, otherwise called sunshine vitamin, and calcium may help women with breast cancer protect against bone loss associated with aromatase inhibitors (AIs), suggests a 5-year follow-up study from Brazil.

Sunshine vitamin, calcium may help avert bone loss associated with AIs

18 Jan 2022

Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life

17 Jan 2022 by

Among patients with epilepsy, quality of life (QOL) declines with antiseizure medication (ASM) polytherapy, and this effect is mediated by depression and the side effects of ASMs, as reported in a study.

Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life

17 Jan 2022

Single antiplatelet therapy causes less GI injury, bleeding than DAPT

17 Jan 2022

Gastrointestinal (GI) injury has developed in almost all patients receiving antiplatelet therapy despite being at low risk of bleeding, reveals a study, noting that overt bleeding is rare.

Single antiplatelet therapy causes less GI injury, bleeding than DAPT

17 Jan 2022

What factors predispose patients to hyperuricaemia following favipiravir treatment?

16 Jan 2022

An already elevated serum uric acid level at baseline and achievement of high steady-state serum favipiravir concentrations during therapy contribute to an increased risk of developing treatment-induced hyperuricaemia, according to a study.

What factors predispose patients to hyperuricaemia following favipiravir treatment?

16 Jan 2022

Just a spoonful of olive oil daily can be life-saving

16 Jan 2022 by

People who consume more olive oil in their diet have a lower risk of death from any cause or specific causes including cardiovascular disease (CVD), cancer, neurodegenerative disease, or respiratory disease compared with those who hardly or never consume olive oil, according to a large US study.

Just a spoonful of olive oil daily can be life-saving

16 Jan 2022

Severe COVID-19: Who is at risk even after full vax?

15 Jan 2022 by

Individuals with risk factors such as pre-existing comorbid conditions, in addition to old age and being immunosuppressed, may still be at increased risk of developing severe COVID-19 illness even after completing their full vaccination, according to a study by the US CDC.

Severe COVID-19: Who is at risk even after full vax?

15 Jan 2022

Study throws light on vaccine hesitancy in Singapore

15 Jan 2022 by

COVID-19 vaccine acceptance is high in Singapore, but there are still a reluctant few who prevent the nation from getting a higher immunization coverage against the infection.

Study throws light on vaccine hesitancy in Singapore

15 Jan 2022

Long-term givosiran use shows sustained clinical benefit in patients with AHP

15 Jan 2022 by

Long-term treatment with givosiran showed continued reduction in the composite annualized attack rate (AAR) of porphyria among patients with acute hepatic porphyria (AHP), according to the ENVISION* open-label extension (OLE) study presented at ASH 2021.

Long-term givosiran use shows sustained clinical benefit in patients with AHP

15 Jan 2022

Pola-R-CHP triumphs over R-CHOP in improving PFS in DLBCL

14 Jan 2022 by

The combination of polatuzumab vedotin with rituximab, cyclophosphamide, doxorubicin, and prednisone (pola-R-CHP) demonstrated a significant improvement in progression-free survival (PFS) over the standard-of-care (SoC) regimen of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with previously untreated diffuse large B-cell lymphoma (DLBCL), according to results of the phase III POLARIX study.

Pola-R-CHP triumphs over R-CHOP in improving PFS in DLBCL

14 Jan 2022

Paediatric VTE: How long should anticoagulation be?

13 Jan 2022 by

A shorter duration of anticoagulant therapy of 6 weeks is as effective in preventing recurrent thrombosis as the conventional 3-month treatment course without increasing the risk of bleeding in young patients aged below 21 years old with acute provoked venous thromboembolism, according to the Kids-DOTT* trial.

Paediatric VTE: How long should anticoagulation be?

13 Jan 2022

News & Updates

Filter by Specialty:

Specialty:

Sunshine vitamin, calcium may help avert bone loss associated with AIs

Sunshine vitamin, calcium may help avert bone loss associated with AIs

Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life

Depression, antiseizure medication side effects take toll on epileptic patients’ quality of life

Single antiplatelet therapy causes less GI injury, bleeding than DAPT

Single antiplatelet therapy causes less GI injury, bleeding than DAPT

What factors predispose patients to hyperuricaemia following favipiravir treatment?

What factors predispose patients to hyperuricaemia following favipiravir treatment?

Just a spoonful of olive oil daily can be life-saving

Just a spoonful of olive oil daily can be life-saving

Severe COVID-19: Who is at risk even after full vax?

Severe COVID-19: Who is at risk even after full vax?

Study throws light on vaccine hesitancy in Singapore

Study throws light on vaccine hesitancy in Singapore

Long-term givosiran use shows sustained clinical benefit in patients with AHP

Long-term givosiran use shows sustained clinical benefit in patients with AHP

Pola-R-CHP triumphs over R-CHOP in improving PFS in DLBCL

Pola-R-CHP triumphs over R-CHOP in improving PFS in DLBCL

Paediatric VTE: How long should anticoagulation be?

Paediatric VTE: How long should anticoagulation be?